# EveryONE Medicines

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/everyone-medicines

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.everyonemedicines.com
- Latest round: Seed (Apr 24, 2024)
- Investors on record: 3

## About

Based in Massachusetts, US, and founded by Julia Vitarello in 2020, EveryONE Medicines Inc. operates as a biotechnology company that develops novel drugs for patients with rare diseases. In April 2024, the firm raised seed funding led by investors Khosla Ventures, GV, and Third Rock Ventures. The firm as of May 2024, is led by its interim CEO, Nessan Bermingham.

The company focuses on research and development of precision therapeutics tailored to the unique genetic mutations of patients. EveryONE Medicines utilizes the next-generation gene sequencing, to detect genetic culprits behind previously undiagnosed diseases. Subsequently, the company develops nucleic acid therapeutics, providing patients with treatments specifically targeting their unique mutations. Additionally, the company's end-to-end support model ensures families receive comprehensive assistance throughout their treatment journey.

The company plans to utilize the April 2024 funding to develop medications for people with certain genetic abnormalities.

## Funding rounds

- Seed, Apr 24, 2024 — Khosla Ventures, Third Rock Ventures, GV

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed
- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Seed
- GV (https://capitalatlas.ai/funds/gv) — Seed